Announced Sat, 11 Jul · 13:06 IST
Investor Complaints Statement Q1 FY27 - Zero Complaints Reported
Compliance View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve
Awaiting price reaction for this filing.
AI summary
MPS Pharmaa Limited (formerly Advik Laboratories) filed its quarterly investor complaints report under SEBI Listing Regulation 13(3) for the quarter ended 30 June 2026. The statement shows zero complaints pending at the start of the quarter, zero received during the quarter, zero disposed of, and zero unresolved at the end. This is a routine compliance filing required of all listed companies every quarter.
Likely market impact
Routine regulatory compliance filing with no material impact on shareholders or stock price.